Table 2 Comparison between the antivenom and the without antivenom groups
From: Effect of antivenom therapy of Rhabdophis tigrinus (Yamakagashi snake) bites
Characteristics | Antivenom group (n = 19) | Without antivenom group (n = 15) | Pvalue |
|---|---|---|---|
Age (years) | 37 (40) | 43 (50) | 0.93 |
Gender, male, n (%) | 18 (94.7) | 15 (100) | 1.00 |
Date of injury, year (2000–2013), n (%) | 7 (36.8) | 2 (13.3) | 0.24 |
Clinical symptoms | |||
Nasal bleeding, n (%) | 1 (5.3) | 3 (20.0) | 0.07 |
Gum bleeding, n (%) | 8 (42.1) | 7 (46.7) | 1.00 |
Bleeding from the bite sites, n (%) | 16 (84.2) | 11 (73.3) | 0.67 |
Headache, n (%) | 3 (15.8) | 3 (20.0) | 1.00 |
Laboratory data | |||
Platelet counts (×104/mm3) | 12.5 (10.1) | 7.9 (11.6) | 0.21 |
Fibrinogen (mg/dL) | 42.5 (20) | 31 (43) | 0.34 |
PT-INR | 5.84 (4.24) | 2.81 (4.11) | 0.1 |
FDP (μg/mL) | 236 (185) | 160 (214) | 0.06 |
DIC score | 5 (4) | 4.5 (3) | 0.6 |
Treatment | |||
Heparin, n (%) | 4 (21.1) | 10 (66.7) | 0.01 |
FFP, n (%) | 3 (15.8) | 5 (38.5) | 0.22 |
PE | 1 (5.3) | 3 (20.0) | 0.30 |